study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir

September 1996

The recently published study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir.

News reports are saying Proscar is "virtually worthless"... prompting lots of calls from concerned patients.

This is the same study we alerted you to last year...it's just now being published in the New England Journal of Medicine.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote